Vir Biotechnology (VIR) Other Non-Current Assets (2018 - 2025)
Historic Other Non-Current Assets for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $16.0 million.
- Vir Biotechnology's Other Non-Current Assets rose 15040.74% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year increase of 15040.74%. This contributed to the annual value of $12.1 million for FY2024, which is 283.67% down from last year.
- Per Vir Biotechnology's latest filing, its Other Non-Current Assets stood at $16.0 million for Q3 2025, which was up 15040.74% from $95.2 million recorded in Q2 2025.
- Vir Biotechnology's 5-year Other Non-Current Assets high stood at $95.2 million for Q2 2025, and its period low was $6.4 million during Q2 2024.
- Its 5-year average for Other Non-Current Assets is $17.3 million, with a median of $7.0 million in 2021.
- In the last 5 years, Vir Biotechnology's Other Non-Current Assets plummeted by 2545.35% in 2023 and then skyrocketed by 139544.45% in 2025.
- Over the past 5 years, Vir Biotechnology's Other Non-Current Assets (Quarter) stood at $7.0 million in 2021, then dropped by 5.0% to $6.7 million in 2022, then surged by 86.43% to $12.4 million in 2023, then decreased by 2.84% to $12.1 million in 2024, then skyrocketed by 32.55% to $16.0 million in 2025.
- Its Other Non-Current Assets stands at $16.0 million for Q3 2025, versus $95.2 million for Q2 2025 and $94.4 million for Q1 2025.